AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33184097 — intervention group
Group type: EXPERIMENTAL
Intervention: UCP (combined with PSA-non-response)
Number of subjects: 736
Study 33184097 — intervention group
Group type: EXPERIMENTAL
Intervention: UCP
Number of subjects: 736
Study 33184097 — intervention group
Group type: EXPERIMENTAL
Intervention: crPFS
Number of subjects: 736
Study 33219016 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (nivo)
Number of subjects: 223
Study 33219016 — intervention group
Group type: COMPARATOR
Intervention: Everolimus (evero)
Number of subjects: 223
Study 33210509 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of somatostatin analogues and glucocorticoids in high risk group (25 patients)
Number of subjects: 78
Study 33210509 — intervention group
Group type: COMPARATOR
Intervention: Somatostatin analogue in control subgroup of high risk group (13 patients)
Number of subjects: 78
Study 33210509 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin analogue in low risk group (18 patients)
Number of subjects: 78
Study 33210509 — intervention group
Group type: COMPARATOR
Intervention: No specific prophylaxis in control subgroup of low risk group (22 patients)
Number of subjects: 78
Study 35057430 — intervention group
Group type: EXPERIMENTAL
Intervention: Early eating window (6:48 ± 0:21 AM)
Number of subjects: 97
Study 35057430 — intervention group
Group type: COMPARATOR
Intervention: Late eating window (8:11 ± 1:05 AM)
Number of subjects: 97
Study 33483796 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinator intervention (LI)
Number of subjects: 141
Study 33647900 — intervention group
Group type: EXPERIMENTAL
Intervention: Serotonin (5-HT) agonistic drugs
Number of subjects: 0
Study 33647900 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenaline (NA) agonistic drugs
Number of subjects: 0
Study 33647900 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (DA) agonistic drugs
Number of subjects: 0
Study 33647900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35273377 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise (aerobic and resistance) for 16 weeks, starting 4 weeks before initiation of ADT and enzalutamide
Number of subjects: 26
Study 35273377 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 26
Study 32928167 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin in addition to a diet and lifestyle intervention
Number of subjects: 511
Study 32928167 — intervention group
Group type: COMPARATOR
Intervention: Diet and lifestyle intervention alone (Control)
Number of subjects: 511
Study 35407378 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischaemic Preconditioning (RIPC)
Number of subjects: 47
Study 35407378 — intervention group
Group type: COMPARATOR
Intervention: Control group (no RIPC)
Number of subjects: 47
Study 32218251 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention with additional initial face-to-face contact
Number of subjects: 336
Study 32218251 — intervention group
Group type: COMPARATOR
Intervention: Web-based intervention
Number of subjects: 336
Study 32218251 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 336
Study 32218251 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related skill ‘dealing with health information’
Number of subjects: 336
Study 33386508 — intervention group
Group type: EXPERIMENTAL
Intervention: VIP-HANA app
Number of subjects: 100
Study 33386508 — intervention group
Group type: COMPARATOR
Intervention: Control app (report symptoms only)
Number of subjects: 100
Study 32998401 — intervention group
Group type: EXPERIMENTAL
Intervention: High personalisation (access to 'Body Balance Beyond' website, individual telehealth coaching via video call, text message support)
Number of subjects: 42
Study 32998401 — intervention group
Group type: EXPERIMENTAL
Intervention: Low personalisation (website only)
Number of subjects: 42
Study 32998401 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 42
Study 32998401 — intervention group
Group type: EXPERIMENTAL
Intervention: High personalisation group
Number of subjects: 42
Study 32998401 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messages
Number of subjects: 42
Study 36149885 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2.5 mg of letrozole and 50 mg of clomiphene citrate (CC)
Number of subjects: 80
Study 36149885 — intervention group
Group type: COMPARATOR
Intervention: Letrozole alone (2.5 mg)
Number of subjects: 80
Study 34120608 — intervention group
Group type: EXPERIMENTAL
Intervention: House Improvement (HI)
Number of subjects: 25000
Study 34120608 — intervention group
Group type: EXPERIMENTAL
Intervention: Larval Source Management (LSM)
Number of subjects: 25000
Study 34120608 — intervention group
Group type: EXPERIMENTAL
Intervention: House Improvement + Larval Source Management (HI + LSM)
Number of subjects: 25000
Study 35125106 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (n=32)
Number of subjects: 95
Study 35125106 — intervention group
Group type: COMPARATOR
Intervention: Brisk walking (n=31)
Number of subjects: 95
Study 35125106 — intervention group
Group type: COMPARATOR
Intervention: No-exercise (n=32)
Number of subjects: 95
Study 33313925 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap (90-min nap from 14:00-15:30)
Number of subjects: 92
Study 33313925 — intervention group
Group type: EXPERIMENTAL
Intervention: HN-nap
Number of subjects: 92
Study 33313925 — intervention group
Group type: EXPERIMENTAL
Intervention: NN-nap
Number of subjects: 92
Study 33313925 — intervention group
Group type: COMPARATOR
Intervention: HN-wake
Number of subjects: 92
Study 33313925 — intervention group
Group type: COMPARATOR
Intervention: NN-wake
Number of subjects: 92
Study 35980909 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectation for learning group (reactivation with expectation)
Number of subjects: 48
Study 35980909 — intervention group
Group type: EXPERIMENTAL
Intervention: No expectation for learning group (reactivation without expectation)
Number of subjects: 48
Study 35980909 — intervention group
Group type: COMPARATOR
Intervention: No reactivation group (no reactivation)
Number of subjects: 48
Study 33886495 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP(3-30)NH2 (1200 pmol/kg/min)
Number of subjects: 10
Study 33886495 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 10
Study 32440838 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal polypropylene mesh (PM)
Number of subjects: 100
Study 32440838 — intervention group
Group type: COMPARATOR
Intervention: Anterior colporrhaphy (AC)
Number of subjects: 100
Study 35653788 — intervention group
Group type: EXPERIMENTAL
Intervention: Low trans fatty acids (TFAs) dietary patterns during pregnancy (< 1% TFAs content)
Number of subjects: 800
Study 35653788 — intervention group
Group type: COMPARATOR
Intervention: Control group with no change in TFAs content
Number of subjects: 800
Study 35653788 — intervention group
Group type: EXPERIMENTAL
Intervention: Low trans fatty acids (TFAs) dietary patterns during pregnancy
Number of subjects: 800
Study 34049171 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfurous-arsenical-ferruginous thermal water inhalation (hot humid air and aerosol)
Number of subjects: 253
Study 34049171 — intervention group
Group type: COMPARATOR
Intervention: Combined inhalation and nasal irrigation of sulfurous-arsenical-ferruginous thermal water
Number of subjects: 253
Study 33289067 — intervention group
Group type: EXPERIMENTAL
Intervention: Practices with higher edge density
Number of subjects: 449460
Study 33289067 — intervention group
Group type: EXPERIMENTAL
Intervention: Practices with higher degree centralization
Number of subjects: 449460
Study 34119901 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous mesenchymal stem cell therapy (MSC)
Number of subjects: 67
Study 34119901 — intervention group
Group type: EXPERIMENTAL
Intervention: Second course of MSC therapy
Number of subjects: 67
Study 34119901 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with AEDs
Number of subjects: 67
Study 33221071 — intervention group
Group type: EXPERIMENTAL
Intervention: Cash incentive ($25, $50) to see a PCP
Number of subjects: 981
Study 35875009 — intervention group
Group type: EXPERIMENTAL
Intervention: Thunder-fire moxibustion
Number of subjects: 90
Study 35875009 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 90
Study 32358836 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1:1 transfusion ratio of plasma and platelets to red blood cells
Number of subjects: 680
Study 32358836 — intervention group
Group type: EXPERIMENTAL
Intervention: 1:1:1 transfusion ratio
Number of subjects: 680
Study 32358836 — intervention group
Group type: COMPARATOR
Intervention: 1:1:2 transfusion ratio
Number of subjects: 680
Study 35837793 — intervention group
Group type: EXPERIMENTAL
Intervention: risdiplam
Number of subjects: 51
Study 35837793 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 51
Study 33406269 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoate (250-1500 mg/d)
Number of subjects: 21
Study 33406269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 33851258 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulating dissector (SD)
Number of subjects: 32
Study 33851258 — intervention group
Group type: COMPARATOR
Intervention: Intermittent stimulating probe (ISP)
Number of subjects: 32
Study 32747208 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored follow-up by a multidisciplinary team
Number of subjects: 301
Study 32747208 — intervention group
Group type: COMPARATOR
Intervention: No follow-up (Control)
Number of subjects: 301
Study 34981231 — intervention group
Group type: EXPERIMENTAL
Intervention: Merged Virtual Reality (MVR) platform
Number of subjects: 30
Study 34981231 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard in-person instruction
Number of subjects: 30
Study 34981231 — intervention group
Group type: COMPARATOR
Intervention: Control group (practice without feedback)
Number of subjects: 30
Study 34266464 — intervention group
Group type: EXPERIMENTAL
Intervention: Health consultation and decision aid using a novel expected frequency tree (EFT)
Number of subjects: 258
Study 34266464 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 258
Study 33567390 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological treatments for BED
Number of subjects: 110
Study 32438245 — intervention group
Group type: EXPERIMENTAL
Intervention: VAC + ITM (MLV-vaccine and ITM - Multimin®90 subcutaneously)
Number of subjects: 45
Study 32438245 — intervention group
Group type: COMPARATOR
Intervention: VAC + SAL (MLV-vaccine and saline)
Number of subjects: 45
Study 32438245 — intervention group
Group type: COMPARATOR
Intervention: UNVAC (unvaccinated)
Number of subjects: 45
Study 35050948 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) at 32‐34 °C
Number of subjects: 3988
Study 35050948 — intervention group
Group type: COMPARATOR
Intervention: Control (normothermia or temperature ≥36 °C)
Number of subjects: 3988
Study 33653744 — intervention group
Group type: EXPERIMENTAL
Intervention: Flash glucose monitoring (FGM)
Number of subjects: 100
Study 33653744 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring of blood glucose
Number of subjects: 100
Study 33092805 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive intraoperative goal-directed therapy (GDT)
Number of subjects: 232
Study 33092805 — intervention group
Group type: COMPARATOR
Intervention: Control group (haemodynamic management left to the discretion of attending senior anaesthetists)
Number of subjects: 232
Study 33092805 — intervention group
Group type: EXPERIMENTAL
Intervention: GDT
Number of subjects: 232
Study 35709823 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term anti-TNF therapy with surgical closure
Number of subjects: 56
Study 35709823 — intervention group
Group type: COMPARATOR
Intervention: Anti-TNF therapy
Number of subjects: 56
Study 33539371 — intervention group
Group type: EXPERIMENTAL
Intervention: Two family meals regularly
Number of subjects: 2743
Study 33539371 — intervention group
Group type: EXPERIMENTAL
Intervention: One regular family meal
Number of subjects: 2743
Study 33539371 — intervention group
Group type: COMPARATOR
Intervention: No regular family meals
Number of subjects: 2743
Study 32982203 — intervention group
Group type: EXPERIMENTAL
Intervention: St. George’s Respiratory Questionnaire (SGRQ) - Symptoms domain
Number of subjects: 0
Study 32982203 — intervention group
Group type: EXPERIMENTAL
Intervention: St. George’s Respiratory Questionnaire (SGRQ) - Activity domain
Number of subjects: 0
Study 32982203 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory RMT analysis for 'Cough and Sputum', 'Breathing difficulties', 'Wheezing attacks'
Number of subjects: 0
Study 32982203 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-cultural analysis of SGRQ 'Activity' items
Number of subjects: 0
Study 34634246 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic ultrasonography-guided care
Number of subjects: 313
Study 34634246 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 313
Study 32593253 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactive vitamin D treatment maintaining levels >34.3 ng/ml for 12 months
Number of subjects: 264
Study 32593253 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactive vitamin D treatment
Number of subjects: 264
Study 32593253 — intervention group
Group type: COMPARATOR
Intervention: Control group treatment according to recommendations of the Russian Association of Endocrinologists
Number of subjects: 264
Study 35522534 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (early-PN)
Number of subjects: 614
Study 35522534 — intervention group
Group type: COMPARATOR
Intervention: Late parenteral nutrition (late-PN)
Number of subjects: 614
Study 35522534 — intervention group
Group type: COMPARATOR
Intervention: Healthy control children
Number of subjects: 614
Study 33891378 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage robotic prostatectomy (S-RARP)
Number of subjects: 24
Study 32438138 — intervention group
Group type: EXPERIMENTAL
Intervention: External Pop-out (EPO) technique
Number of subjects: 910
Study 32438138 — intervention group
Group type: COMPARATOR
Intervention: Classic technique
Number of subjects: 910
Study 32773596 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (sucrose, massage, music, non-nutritive sucking, gentle human touch)
Number of subjects: 76
Study 32773596 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions
Number of subjects: 76
Study 32773596 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 76
Study 32310005 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (performed at least twice within 6 weeks)
Number of subjects: 182901
Study 32310005 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupuncture treatment)
Number of subjects: 182901
Study 33211517 — intervention group
Group type: EXPERIMENTAL
Intervention: Web‐PE
Number of subjects: 74
Study 33211517 — intervention group
Group type: COMPARATOR
Intervention: PCT
Number of subjects: 74
Study 32557087 — intervention group
Group type: EXPERIMENTAL
Intervention: POC coagulation tests
Number of subjects: 162
Study 32557087 — intervention group
Group type: COMPARATOR
Intervention: Conventional laboratory coagulation tests (control group)
Number of subjects: 162
Study 34389374 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable-related norm message
Number of subjects: 12994
Study 34389374 — intervention group
Group type: COMPARATOR
Intervention: Neutral-behavior norm message (Control)
Number of subjects: 12994
Study 35290614 — intervention group
Group type: EXPERIMENTAL
Intervention: Valvular surgery
Number of subjects: 912
Study 35290614 — intervention group
Group type: COMPARATOR
Intervention: Surgery performed
Number of subjects: 912
Study 34542038 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency (LF-) rTMS (n=14)
Number of subjects: 28
Study 34542038 — intervention group
Group type: COMPARATOR
Intervention: Sham-rTMS (n=14)
Number of subjects: 28
Study 36207143 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersion in water at 20‐30°C (20 min/day for 4 weeks)
Number of subjects: 76
Study 36207143 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study 33973300 — intervention group
Group type: EXPERIMENTAL
Intervention: Linked Color Imaging (LCI)
Number of subjects: 995
Study 33973300 — intervention group
Group type: COMPARATOR
Intervention: White Light Imaging (WLI)
Number of subjects: 995
Study 32730920 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP receptor antagonist GIP(3-30)NH2
Number of subjects: 30
Study 32730920 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 receptor antagonist exendin(9–39)NH2
Number of subjects: 30
Study 32730920 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30
Study 32730920 — intervention group
Group type: EXPERIMENTAL
Intervention: Both GIP(3-30)NH2 and exendin(9–39)NH2
Number of subjects: 30
Study 34791018 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery
Number of subjects: 29
Study 34791018 — intervention group
Group type: COMPARATOR
Intervention: Traditional surgery
Number of subjects: 29
Study 34628926 — intervention group
Group type: EXPERIMENTAL
Intervention: Loose combined cutting seton (LCCS)
Number of subjects: 76
Study 34628926 — intervention group
Group type: COMPARATOR
Intervention: Traditional cutting seton (CS)
Number of subjects: 76
Study 35181200 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 0
Study 35181200 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 34031240 — intervention group
Group type: EXPERIMENTAL
Intervention: Storytelling intervention (30 minutes)
Number of subjects: 0
Study 34031240 — intervention group
Group type: COMPARATOR
Intervention: Active control (solving riddles with social interaction)
Number of subjects: 0
Study 36434687 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual therapy (MT) for 20 min per session, 6 sessions total, once every two days.
Number of subjects: 17
Study 36434687 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise (TE) for 30 min per session, 6 sessions total, once every two days.
Number of subjects: 17
Study 33532952 — intervention group
Group type: EXPERIMENTAL
Intervention: e-Familias Unidas
Number of subjects: 93
Study 33532952 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 93
Study 32564453 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (BAK)
Number of subjects: 36
Study 32564453 — intervention group
Group type: COMPARATOR
Intervention: Preservative-free (PF)
Number of subjects: 36
Study 32564453 — intervention group
Group type: COMPARATOR
Intervention: Polyquad (PQ)
Number of subjects: 36
Study 35352382 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of unexposed clusters in fixed effects LSDV analysis
Number of subjects: 0
Study 35352382 — intervention group
Group type: COMPARATOR
Intervention: Standard fixed effects LSDV analysis without unexposed clusters
Number of subjects: 0
Study 34153318 — intervention group
Group type: EXPERIMENTAL
Intervention: 11β-MNTDC
Number of subjects: 42
Study 34153318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 36180142 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates method (PM) protocol, 16 sessions, twice a week (n=33)
Number of subjects: 62
Study 36180142 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) without intervention (n=29)
Number of subjects: 62
Study 33737427 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of Pozzi tenaculum forceps during IUI
Number of subjects: 800
Study 33737427 — intervention group
Group type: COMPARATOR
Intervention: Standard care treatment without Pozzi tenaculum forceps during IUI
Number of subjects: 800
Study 33737427 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care treatment with Pozzi tenaculum forceps during IUI
Number of subjects: 800
Study 33737427 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions performed by attendings
Number of subjects: 800
Study 35218680 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional platelet-rich plasma (PRP) injections
Number of subjects: 20
Study 35218680 — intervention group
Group type: COMPARATOR
Intervention: Intralesional triamcinolone acetonide (TA) injections
Number of subjects: 20
Study 32715653 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-managed dosing algorithm for darbepoetin alfa (DA) and iron sucrose
Number of subjects: 200
Study 32715653 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study 34126650 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D macula scan method (3DM)
Number of subjects: 39
Study 34126650 — intervention group
Group type: EXPERIMENTAL
Intervention: Line scan method 1 (LM1)
Number of subjects: 39
Study 34126650 — intervention group
Group type: EXPERIMENTAL
Intervention: Line scan method 2 (LM2)
Number of subjects: 39
Study 34403548 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral midazolam
Number of subjects: 90
Study 34403548 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 µg/kg oral clonidine
Number of subjects: 90
Study 34403548 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 µg/kg intranasal dexmedetomidine
Number of subjects: 90
Study 34403548 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 32016407 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative condition with graphical opioid history and noninterruptive CDS
Number of subjects: 24
Study 32016407 — intervention group
Group type: COMPARATOR
Intervention: Conventional condition with tabular format and interruptive modal dialogs
Number of subjects: 24
Study 35370406 — intervention group
Group type: EXPERIMENTAL
Intervention: CFHealthHub intervention (objective adherence data)
Number of subjects: 22
Study 32890429 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia Self-Management Programme (FSMP)
Number of subjects: 70
Study 32890429 — intervention group
Group type: COMPARATOR
Intervention: Control arm (not specified)
Number of subjects: 70
Study 34855419 — intervention group
Group type: COMPARATOR
Intervention: Standard weight loss intervention
Number of subjects: 64
Study 34855419 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention with training to enhance autonomy support behavior
Number of subjects: 64